Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - colecalciferol; calcium carbonate; risedronate sodium -

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

theramex ireland ltd. - sodium risedronate 35 mg - eq. risedronic acid 32,5 mg (film-coated tablet); calcium carbonate 2500 mg - eq. calcium 1000 mg (effervescent granules); cholecalciferol 880 iu (effervescent granules) - film-coated tablet; effervescent granules - 35 mg - 1000 mg - 880 iu - cholecalciferol 880 iu; risedronate sodium 35 mg; calcium carbonate 2500 mg - risedronic acid, calcium and colecalciferol, sequential

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 40.17 mg (equivalent: risedronate sodium, qty 35 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; lactose monohydrate; magnesium stearate; hyprolose; titanium dioxide; macrogol 8000; hypromellose; colloidal anhydrous silica; iron oxide yellow; iron oxide red; macrogol 400 - ? treatment of osteoporosis,? treatment of glucocorticoid-induced osteoporosis,? preservation of bone mineral density in patients on long term corticosteroid therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 34.43 mg (equivalent: risedronate sodium, qty 30 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; hyprolose; crospovidone; microcrystalline cellulose; magnesium stearate; hypromellose; macrogol 400; titanium dioxide - treatment of paget?s disease of bone

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 5.74 mg (equivalent: risedronate sodium, qty 5 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; crospovidone; hyprolose; titanium dioxide; hypromellose; macrogol 8000; colloidal anhydrous silica; iron oxide yellow; macrogol 400 - ? treatment of osteoporosis,? treatment of glucocorticoid-induced osteoporosis,? preservation of bone mineral density in patients on long term corticosteroid therapy

Canada - English - Health Canada

aa pharma inc - risedronate sodium (risedronate sodium hemipentahydrate) - tablet (delayed-release) - 35mg - risedronate sodium (risedronate sodium hemipentahydrate) 35mg - bone resorption inhibitors

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - risedronate sodium - film-coated tablet - risedronate sodium 5 mg - drugs for treatment of bone diseases

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - risedronate sodium - film-coated tablet - risedronate sodium 30 mg - drugs for treatment of bone diseases

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - risedronate sodium - film-coated tablet - risedronate sodium 35 mg - drugs for treatment of bone diseases

Canada - English - Health Canada

warner chilcott canada co - risedronate sodium; calcium (calcium carbonate); vitamin d3 - granules (effervescents) - 35mg; 1000mg; 880unit - risedronate sodium 35mg; calcium (calcium carbonate) 1000mg; vitamin d3 880unit - bone resorption inhibitors